|
|
Name: |
Affinity Asset Advisors LLC |
City: |
Bridgehampton |
State: |
NY |
Zip: |
11932 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
Decreased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
CBAY |
Cymabay Therapeutics, Inc. |
3 |
- |
$32.48 |
$25,756,000 |
1,090,441 |
5.43% |
8,917,000 |
-38,935 |
1.151 |
N/A |
|
TEVA |
Teva Pharmaceutical Industr... |
6 |
- |
$16.25 |
$19,836,000 |
1,900,000 |
4.19% |
-564,000 |
-100,000 |
0.173 |
Drug Manufacturers - ... |
|
ACLX |
Arcellx, Inc. |
7 |
- |
$0.00 |
$18,870,000 |
340,000 |
3.98% |
4,518,000 |
-60,000 |
0.694 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
9 |
- |
$48.00 |
$15,908,000 |
447,095 |
3.36% |
2,525,000 |
-2,905 |
0.771 |
N/A |
|
APGE |
Apogee Therapeutics, Inc. |
11 |
- |
$53.22 |
$15,006,000 |
537,093 |
3.17% |
-7,255,000 |
-508,017 |
1.444 |
N/A |
|
CYTK |
Cytokinetics Inc |
13 |
- |
$62.10 |
$13,358,000 |
160,000 |
2.82% |
6,571,000 |
-70,366 |
0.141 |
Biotechnology |
|
AUTL |
Autolus Therapeutics Plc |
18 |
- |
$3.99 |
$9,985,000 |
1,550,408 |
2.11% |
5,343,000 |
-442,058 |
0.896 |
N/A |
|
CNTA |
Centessa Pharmaceuticals Plc |
22 |
- |
$0.00 |
$6,334,000 |
795,729 |
1.34% |
-253,000 |
-222,362 |
0.91 |
N/A |
|
ESTA |
Establishment Labs Holdings... |
23 |
- |
$55.96 |
$5,910,000 |
228,277 |
1.25% |
-5,823,000 |
-10,831 |
0.974 |
N/A |
|
KRYS |
Krystal Biotech Inc |
37 |
- |
$154.76 |
$3,102,000 |
25,000 |
0.65% |
-3,568,000 |
-32,500 |
0.1 |
N/A |
|
TNGX |
Tango Therapeutics Ord Shs |
39 |
- |
$0.00 |
$2,973,000 |
300,274 |
0.63% |
-968,000 |
-49,726 |
0.343 |
N/A |
|
KURA |
Kura Oncology Inc |
41 |
- |
$20.71 |
$2,754,000 |
191,535 |
0.58% |
-5,058,000 |
-665,000 |
0.251 |
N/A |
|
ASND |
Ascendis Pharma AS |
43 |
- |
$133.46 |
$2,519,000 |
20,000 |
0.53% |
-1,826,000 |
-26,400 |
0.031 |
N/A |
|
MRSN |
Mersana Therapeutics, Inc. |
44 |
- |
$2.71 |
$2,320,000 |
1,000,000 |
0.49% |
-1,300,000 |
-1,850,000 |
0.892 |
N/A |
|
TRML |
Tourmaline Bio |
47 |
- |
$0.00 |
$1,782,000 |
68,081 |
0.38% |
658,000 |
-331,919 |
0.165 |
N/A |
|
ADCT |
ADC Therapeutics Sa |
48 |
- |
$4.30 |
$1,682,000 |
1,013,540 |
0.35% |
695,000 |
-86,460 |
1.433 |
N/A |
|
KALV |
Kalvista Pharmaceuticals Inc |
50 |
- |
$12.08 |
$1,543,000 |
125,969 |
0.33% |
-1,137,000 |
-152,323 |
0.373 |
N/A |
|
MORF |
Morphic Holding, Inc. |
56 |
- |
$28.62 |
$1,232,000 |
42,670 |
0.26% |
-4,954,000 |
-227,330 |
0.111 |
N/A |
|
BHVN |
Biohaven Ltd. |
58 |
- |
$35.69 |
$893,000 |
20,866 |
0.19% |
109,000 |
-9,290 |
0.031 |
N/A |
|
TERN |
Terns Pharmaceuticals, Inc. |
63 |
- |
$5.56 |
$428,000 |
66,000 |
0.09% |
-1,207,000 |
-259,000 |
0.118 |
N/A |
|
IFRX |
InflaRx NV |
66 |
- |
$1.18 |
$326,000 |
200,097 |
0.07% |
-643,000 |
-125,000 |
0.855 |
N/A |
|